BATS:ARKG ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News $51.64 +0.05 (+0.10%) Closing price 09/18/2026 04:10 PM EasternExtended Trading$52.06 +0.42 (+0.81%) As of 09/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsNews and TrendsOwnershipRatingsShort Interest About ARK Genomic Revolution ETF (BATS:ARKG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get ARKG alerts:Sign Up Key Stats Today's Range$50.93▼$52.0850-Day Range$37.50▼$51.6452-Week Range$24.60▼$52.09Volume6.72 million shsAverage Volume3.15 million shsMarket Capitalization$2.31 billionAssets Under Management$2.21 billionDividend YieldN/ANet Expense Ratio0.75%Aggregate RatingModerate Buy ETF Overview The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK. Read More ARK Genomic Revolution ETF ExpensesTypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.75%0.57%0.57%0.60%0.53%Other Expenses0.00%0.57%0.53%0.49%0.54%Total Expense0.75%0.72%0.75%0.73%0.73%Fee Waiver0.00%-0.72%-0.67%-0.54%-0.68%Net Expense0.75%0.60%0.63%0.66%0.60% Receive ARKG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARKG ETF News HeadlinesCathie Wood's ARK Invest buys AVAV stock again, trims GOOGL stake and sells IridiumSeptember 16 at 7:06 AM | msn.comWhat is Cathie Wood buying now? Nvidia, SpaceX and crypto stocks led ARK’s August trades – while cutting these growth stocksSeptember 1, 2026 | msn.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.September 19 at 1:00 AM | Base Camp Trading (Ad)ARKG: Dividendenhistorie, Rendite und Ex-Dividenden-TagAugust 21, 2026 | de.investing.comARKG: Caught In The Tech Sell-Off, But Here's Why The Dip Is BuyableJuly 28, 2026 | seekingalpha.comETF Showdown: ARKG vs GNOM, Which Genomics Fund Wins?July 21, 2026 | 247wallst.comSee More Headlines ARKG ETF - Frequently Asked Questions How have ARKG shares performed this year? ARK Genomic Revolution ETF's stock was trading at $28.9250 on January 1st, 2026. Since then, ARKG shares have increased by 78.5% and is now trading at $51.64. Who are ARK Genomic Revolution ETF's major shareholders? Top institutional shareholders of ARK Genomic Revolution ETF include Baird Financial Group Inc. (0.16%), Client First Investment Management LLC (0.14%), Turner Financial Group Inc. (0.09%) and Nwam LLC (0.07%). How do I buy shares of ARK Genomic Revolution ETF? Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of ARK Genomic Revolution ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that ARK Genomic Revolution ETF investors own include Invesco QQQ (QQQ), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AbbVie (ABBV) and PayPal (PYPL). Fund Details IssuerARK Fund NameARK Genomic Revolution ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:ARKG Inception Date10/31/2014 Fund ManagerCatherine Wood WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings34 Fund Statistics Assets Under Management$2.21 billion Average Daily Volume$4.67 million Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorARK Investment Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerJane Street Options OptionableOptionable Options Volume27,171 Put Options17,453 Call Options9,718 Short Interest27,229,407 shs Miscellaneous Outstanding Shares44,700,000Beta1.62 Creation Fee$500.00 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report Top 10 ARKG Holdings10x Genomics (NASDAQ:TXG)Holding Weight: 9.13%Twist Bioscience (NASDAQ:TWST)Holding Weight: 8.57%Tempus AI (NASDAQ:TEM)Holding Weight: 7.88%CRISPR Therapeutics (NASDAQ:CRSP)Holding Weight: 6.14%Personalis (NASDAQ:PSNL)Holding Weight: 5.93%Absci (NASDAQ:ABSI)Holding Weight: 4.82%Guardant Health (NASDAQ:GH)Holding Weight: 4.44%Natera (NASDAQ:NTRA)Holding Weight: 4.08%Illumina (NASDAQ:ILMN)Holding Weight: 3.95%Eli Lilly and Company (NYSE:LLY)Holding Weight: 3.90%Full Holdings DetailsARKG Sector ExposureARKG Industry Exposure This page (BATS:ARKG) was last updated on 9/19/2026 by MarketBeat.com Staff. From Our PartnersBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARKG Stock Alerts